Related Experiment Video
Updated: Mar 26, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Fibroblast Growth Factor Signaling in Metabolic Regulation
Vera J M Nies1, Gencer Sancar2, Weilin Liu1
1Center for Liver, Digestive and Metabolic Diseases, Department of Pediatrics, University Medical Center Groningen, University of Groningen , Groningen , Netherlands.
Abstract:
The prevalence of obesity is a growing health problem. Obesity is strongly associated with several comorbidities, such as non-alcoholic fatty liver disease, certain cancers, insulin resistance, and type 2 diabetes, which all reduce life expectancy and life quality. Several drugs have been put forward in order to treat these diseases, but many of them have detrimental side effects. The unexpected role of the family of fibroblast growth factors in the regulation of energy metabolism provides new approaches to the treatment of metabolic diseases and offers a valuable tool to gain more insight into metabolic regulation. The known beneficial effects of FGF19 and FGF21 on metabolism, together with recently discovered similar effects of FGF1 suggest that FGFs and their derivatives carry great potential as novel therapeutics to treat metabolic conditions. To facilitate the development of new therapies with improved targeting and minimal side effects, a better understanding of the molecular mechanism of action of FGFs is needed. In this review, we will discuss what is currently known about the physiological roles of FGF signaling in tissues important for metabolic homeostasis. In addition, we will discuss current concepts regarding their pharmacological properties and effector tissues in the context of metabolic disease. Also, the recent progress in the development of FGF variants will be reviewed. Our goal is to provide a comprehensive overview of the current concepts and consensuses regarding FGF signaling in metabolic health and disease and to provide starting points for the development of FGF-based therapies against metabolic conditions.
Insights
Fibroblast growth factors (FGFs) show promise for treating metabolic diseases like obesity and diabetes. Understanding FGF signaling mechanisms is key to developing effective FGF-based therapies with fewer side effects.
Area of Science:
- Metabolic diseases
- Endocrinology
- Molecular biology
Background:
- Obesity is a growing health concern linked to serious comorbidities like type 2 diabetes and non-alcoholic fatty liver disease.
- Current treatments for metabolic diseases often have adverse effects.
- Fibroblast growth factors (FGFs) play a crucial role in regulating energy metabolism.
Purpose of the Study:
- To review the physiological roles of FGF signaling in metabolic homeostasis.
- To discuss the pharmacological properties and effector tissues of FGFs in metabolic disease.
- To summarize recent advancements in FGF variant development for therapeutic applications.
Main Methods:
- Literature review of current research on FGF signaling in metabolic health and disease.
- Analysis of the known and potential therapeutic applications of FGFs and their derivatives.
- Examination of the molecular mechanisms underlying FGF action.
Main Results:
- FGF1, FGF19, and FGF21 exhibit beneficial metabolic effects.
- FGF signaling pathways are critical for maintaining metabolic balance.
- Developing FGF variants offers potential for targeted therapies with improved safety profiles.
Conclusions:
- FGFs represent a promising therapeutic avenue for metabolic conditions.
- Further understanding of FGF molecular mechanisms is essential for optimizing FGF-based treatments.
- Targeted FGF therapies could offer improved efficacy and reduced side effects for metabolic diseases.
More Related Videos
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
08:03Live-Cell Förster Resonance Energy Transfer Imaging of Metabolically Regulated Akt Activation Dynamics in HepG2 Cells
Published on: May 23, 2025
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Regulation of Metabolism
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Introduction to Fibroblasts